Comparative effects of sulphonylureas, dipeptidyl peptidase‐4 inhibitors and sodium‐glucose co‐transporter‐2 inhibitors added to metformin monotherapy: a propensity‐score matched cohort study in UK primary care

AIM: To assess the comparative effects of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors, sulphonylureas (SUs) and dipeptidyl peptidase‐4 (DPP‐4) inhibitors on cardiometabolic risk factors in routine care. MATERIALS AND METHODS: Using primary care data on 10 631 new users of SUs, SGLT2 inhibitor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes Obes Metab
Hauptverfasser: Wilkinson, Samantha, Williamson, Elizabeth, Pokrajac, Ana, Fogarty, Damian, Stirnadel‐Farrant, Heide, Smeeth, Liam, Douglas, Ian J., Tomlinson, Laurie A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Blackwell Publishing Ltd 2020
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7187358/
https://ncbi.nlm.nih.gov/pubmed/31957254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13970
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge